Browsing: Homepage Slider
WHO have announced plans to include biosimilars for cancer treatments as part of their current prequalifying scheme, in the hope to make treatment more available in low income countries.
Thermo Fisher (MA, USA) is set to buy Patheon (NC, USA) for $5.2 billion to expand biopharmaceutical services.
Novel ‘heart-on-a-chip’ technology could measure compound effects on heart tissue function in the hope of ensuring safety and efficiently of new drugs.
In December 2015, the Reid Bioanalytical Forum entered a new era with a new committee…
The CRO BioPharmaSpec, have announced plans to increase in-house capabilities, including the 3D structure characterization of proteins.
In this podcast, we speak with Erik Burns and Jim De Muth to find out…
Plasma protein binding monitoring of therapeutic drugs in patients using single set of hollow fiber centrifugal ultrafiltration
In this study, a novel method was proposed to analyze free drug concentration and total drug concentration.
Live event: Thursday, May 25, 2017 at 07:00 [PDT] 10:00 [EDT] 15:00 [BST]
In this mini-webinar you will learn about different LC-MS/MS approaches for quantitative protein bioanalysis with focus on biopharmaceuticals, biomarkers and targeted proteomics.